WallStreetZenWallStreetZen

NASDAQ: FATE
Fate Therapeutics Inc Stock Ownership - Who owns Fate Therapeutics?

Insider buying vs selling

Have Fate Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Edward J. Dulac IiiChief Financial Officer2024-03-042,447$7.77
$19.01kSell
Edward J. Dulac IiiChief Financial Officer2024-01-291,849$5.00
$9.25kSell
Cindy TahlGeneral Counsel and Secretary2024-01-0910,874$4.37
$47.52kSell
Edward J. Dulac IiiChief Financial Officer2024-01-097,028$4.37
$30.71kSell
J. Scott WolchkoPresident and CEO2024-01-0914,391$4.37
$62.89kSell
Bahram ValamehrChief RD Officer2024-01-0911,271$4.38
$49.37kSell
Edward J. Dulac IiiChief Financial Officer2024-01-025,182$3.66
$18.97kSell
Redmile Group LLCDirector2023-12-2644,630$3.72
$166.02kBuy
Redmile Group LLCDirector2023-12-261,655,370$3.72
$6.16MBuy
Redmile Group LLCDirector2023-12-261,655,370$3.72
$6.16MSell

1 of 2

FATE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FATE insiders and whales buy or sell their stock.

FATE Shareholders

What type of owners hold Fate Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC22.97%26,148,941$94.40MInsider
Redmile Group LLC11.57%13,169,057$47.54MInstitution
Vanguard Group Inc8.71%9,911,007$35.78MInstitution
Amir Nashat8.66%9,852,967$35.57MInsider
Polaris Venture Management Co V LLC8.65%9,841,933$35.53MInsider
Blackrock Inc7.99%9,099,951$32.85MInstitution
Boxer Capital LLC7.22%8,215,910$29.66MInstitution
State Street Corp7.06%8,036,669$29.01MInstitution
Deep Track Capital LP4.90%5,572,607$20.12MInstitution
Bellevue Group Ag4.25%4,839,779$17.47MInstitution

1 of 3

FATE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FATE67.68%32.32%Net Selling
KYTX57.89%42.11%Net BuyingNet Buying
PGEN24.42%72.43%Net BuyingNet Selling
CTNM0.00%10.47%
TBPH58.74%41.26%Net BuyingNet Buying

Fate Therapeutics Stock Ownership FAQ

Who owns Fate Therapeutics?

Fate Therapeutics (NASDAQ: FATE) is owned by 108.08% institutional shareholders, 51.60% Fate Therapeutics insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Fate Therapeutics shareholder, owning 26.15M shares representing 22.97% of the company. Redmile Group LLC's Fate Therapeutics shares are currently valued at $94.40M.

If you're new to stock investing, here's how to buy Fate Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.